Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The normal human prostate does not significantly affect blood DHT levels.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

A gene called BMAL1 plays a role in controlling hair growth.

Bald men may have a lower risk of testicular cancer.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Androgens and other hormones affect hair growth and skin conditions like acne.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Multiple treatments work best for hair loss.

DHT, a testosterone byproduct, causes male pattern baldness.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Red Ginseng Extract may help human hair grow by activating growth pathways and blocking negative effects of certain hormones.